AIRS:NSD-Airsculpt Technologies Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 6.51

Change

-0.45 (-6.47)%

Market Cap

USD 0.40B

Volume

0.35M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

USD 8.88B
OPCH Option Care Health Inc

N/A

USD 4.10B
SGRY Surgery Partners Inc

N/A

USD 3.65B
ACHC Acadia Healthcare Company Inc

N/A

USD 3.51B
AMED Amedisys Inc

N/A

USD 2.95B
LFST Lifestance Health Group Inc

N/A

USD 2.61B
ADUS Addus HomeCare Corporation

N/A

USD 2.17B
ASTH Astrana Health Inc

N/A

USD 1.86B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.08B
HCSG Healthcare Services Group Inc

N/A

USD 0.81B

ETFs Containing AIRS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.08% 62% D 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.08% 62% D 37% F
Trailing 12 Months  
Capital Gain 31.78% 85% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.78% 85% B 74% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -9.53% 42% F 22% F
Dividend Return -9.53% 42% F 21% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.58% 54% F 49% F
Risk Adjusted Return -24.71% 42% F 22% F
Market Capitalization 0.40B 58% F 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.